Diazyme Laboratories, Inc.

Home
United States
Poway, CA
Diazyme Laboratories, Inc.

Diazyme is a clinical chemistry reagent manufacturer that develops IVD assays for use on conventional open channel automated chemistry platforms.

02/05/2026

What Is the PLAC test?

The PLAC® Test for Lp-PLA2 Activity (PLAC Activity) is the only FDA cleared test for Lp-PLA2 activity with a clinically validated cut-point and is exclusively offered by Diazyme Laboratories!

Learn how to advance your laboratories by adding PLAC today! Visit this site to learn more:
https://bit.ly/3UH7BGf

02/03/2026

February is American Heart Month ❤️

Cardiovascular disease remains the leading cause of death worldwide, but early detection can save lives. Diazyme’s Cardiovascular Panel offers fast, reliable insights to help identify risks and support better heart health management.

From Lp-PLA₂ (PLAC™) for vascular inflammation to oxLDL for assessing oxidative stress, our assays provide the tools clinicians need for proactive care. Let’s work together to make heart health a priority!

Learn more: https://bit.ly/3MlnU6y

02/02/2026

One week to go until WHX Labs Dubai, February 10–13. We’re looking forward to connecting with industry leaders and discussing the latest advances in clinical diagnostics.

📍 Visit us at Booth H3.G16
📅 Schedule your one-on-one meeting with our team today - https://bit.ly/4jtxWT3

We look forward to seeing you in Dubai.

01/27/2026

What Sets Diazyme Laboratories Apart?

At Diazyme Laboratories, we pride ourselves on offering diagnostic solutions that lead the industry in innovation and reliability. Here’s what makes us stand out:

🔬 Innovative Technology: Our assays are designed with cutting-edge technology to deliver precise and dependable results. Our solutions support early detection and effective management across various medical conditions.

💡 Comprehensive Assay Menu: We provide an extensive range of FDA-cleared assays, covering a wide array of diagnostic needs. This breadth ensures our clients have access to comprehensive diagnostic tools for diverse applications.

📈 High-Performance Efficiency: With products like the DZ-Lite™ c270 analyzer, we offer rapid and accurate results with high throughput. Our solutions enhance efficiency, enabling healthcare professionals to make timely and informed decisions.

🛠️ User-Friendly Design: Our instruments are crafted for ease of use and seamless integration. From intuitive interfaces to compact designs, we prioritize user experience to fit diverse clinical environments.

🌍 Commitment to Quality: Quality and reliability are at the core of our mission. We are committed to continuous improvement, ensuring that our diagnostic tools meet the highest standards of excellence.

Discover how Diazyme Laboratories can enhance your diagnostic capabilities and support better patient outcomes: https://bit.ly/36lKaaV

01/22/2026

Comprehensive Cardiovascular Insights with Diazyme’s Advanced Biomarkers ❤️🔬

Cardiovascular disease remains a leading health challenge, but early detection through reliable biomarkers can change outcomes. At Diazyme Laboratories, we offer a comprehensive suite of cardiovascular markers to support early risk assessment, diagnosis, and proactive care.

Our innovative assays help clinicians assess critical risk factors by monitoring the following biomarkers:

🩺 Key Cardiovascular Markers:

• PLAC (Phospholipase A2): A key indicator linked to inflammation and cardiovascular disease risk.
• OxPL (Oxidized Phospholipids): Markers of oxidative stress and atherosclerosis progression.
• OxLDL (Oxidized LDL): A critical biomarker for atherosclerosis and cardiovascular risk.
• Homocysteine: Elevated levels associated with endothelial dysfunction and cardiovascular disease.
• HDL3 (High-Density Lipoprotein Subfraction): A protective lipoprotein that supports cardiovascular health.
• ApoB (Apolipoprotein B): A marker for LDL particles and cardiovascular risk assessment.
• HDL & LDL: Assessments of cholesterol levels to determine cardiovascular risk.
• Lp(a) (Lipoprotein(a)): A genetic risk marker linked to cardiovascular disease.
💡 Why These Markers Matter:
These biomarkers provide a window into inflammation, cholesterol health, endothelial dysfunction, and other pathways critical to cardiovascular health. Early detection allows for timely, evidence-based strategies to reduce risk and improve outcomes.

Take control of cardiovascular health with Diazyme’s trusted diagnostic solutions.

👉 Learn how our testing can support your clinical goals and help improve patient care.: https://bit.ly/3MlnU6y

(a)

01/21/2026

Heading to WHX Labs 2026? Let’s connect.

We’re excited to be exhibiting at this year’s World Health Expo Labs and showcasing our latest innovations in clinical diagnostics, including new research-use panels, high-sensitivity assays, and laboratory automation platform.

If you’re attending, now is the perfect time to schedule a meeting with our team. Whether you're interested in expanding your assay menu, exploring new research tools, or discussing partnership opportunities, we’d love to talk.

📅 Secure your meeting slot in advance to get a personalized look at what’s new and what’s coming next: https://bit.ly/4jtxWT3

01/20/2026

Now Hiring!

Join Diazyme – Innovating Diagnostics for a Healthier World!

We are seeking a dynamic Regional Sales Representative – Diagnostic Medical Devices to drive business growth and build strong customer relationships across the South-Central Region (TX, CO, OK, KS, NE, MO, AR).

What You’ll Do:
- Develops market/product line business plans and capture plans to support sales in designated market segments.
- Advises management on status or action required in connection with existing and potential sales programs.
- Assists in supplying business development input and administrative control for specific projects within the group.
- Analyze market trends to uncover new opportunities.

Make a difference in healthcare today!

Apply now: https://bit.ly/4pwXDnd

01/15/2026

Elevating Lipid Diagnostics with Diazyme's Lp(a) Assay

At Diazyme Laboratories, we’re committed to supporting the advancement of cardiovascular diagnostics with solutions that deliver accuracy, reliability, and clinical relevance. Our Lipoprotein (a) [Lp(a)] Assay is designed to provide dependable results that are essential for evaluating independent cardiovascular risk, particularly in individuals with a family history of premature heart disease.

Key advantages of Diazyme’s Lp(a) Assay:
• Reports in both mg/dL and nmol/L to align with current clinical recommendations
• Fully automated and compatible with most chemistry analyzers
• Traceable to the WHO/IFCC reference material SRM 2B
• Wide measuring range and excellent precision
• Minimal interference from triglycerides, bilirubin, hemoglobin, and ascorbic acid

As lipid testing standards continue to evolve, Diazyme remains focused on equipping laboratories with solutions that enhance clinical decision-making and support proactive cardiovascular care.

Learn more: https://bit.ly/4l6Anea

01/14/2026

Diazyme Laboratories, Inc. announces 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the evaluation of monoclonal gammopathy of undetermined significance (MGUS) using Diazyme’s Kappa and Lambda Free Light Chain Assays.

👉 Read the full press release: https://bit.ly/4pFf3Or

01/14/2026

Why Monitor Kappa & Lambda Free Light Chains?

Normally, there's a balance between kappa and lambda free light chains in the bloodstream. However, in certain diseases, particularly plasma cell disorders such as multiple myeloma, there can be an imbalance in the production of these free light chains. This imbalance can lead to an excess of one type of light chain over the other, which is known as a kappa-lambda ratio imbalance.

This imbalance can be detected through laboratory tests, such as Diazyme’s Kappa and Lambda serum free light chain assays, which measures the levels of kappa and lambda free light chains in the blood. Monitoring the kappa-lambda ratio is important in the diagnosis and management of plasma cell disorders.

Learn More about these assays and to support healthcare providers in assessing disease progression and response to treatment.
https://bit.ly/4h7z6kn

01/12/2026

We’re excited to announce that Diazyme will be attending the World Health Expo Labs this year! 🎉

Join us at block H3.G16 to explore our latest innovations in diagnostics and see how our cutting-edge assays and instruments are making a difference in patient care. Our team will be on hand to showcase our products, discuss the future of diagnostics, and answer any questions you may have.

We can’t wait to connect with industry experts, healthcare professionals, and innovators who are shaping the future of diagnostics. Don’t miss the chance to learn more about what makes Diazyme a leader in the field.

See you at WHX Labs! 👋

Register to attend today: https://bit.ly/4blZI1I

01/07/2026

Welcome Back!

With a new year comes new excitement for innovations and accomplishments.

What are you looking forward to in the Clinical Chemistry space for 2026?

https://bit.ly/36lKaaV

Address

12889 Gregg Court
Poway, CA
92064

Website

http://www.diazyme.com/

Alerts

Be the first to know and let us send you an email when Diazyme Laboratories, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your practice to be the top-listed Clinic in Poway?